| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Tianjin Tianyao Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.54 |
| 52 Week High | CN¥5.72 |
| 52 Week Low | CN¥3.10 |
| Beta | 0.29 |
| 11 Month Change | -14.08% |
| 3 Month Change | -13.45% |
| 1 Year Change | -35.28% |
| 33 Year Change | -22.88% |
| 5 Year Change | -17.87% |
| Change since IPO | -66.42% |
Recent News & Updates
Shareholder Returns
| 600488 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -6.1% | -3.2% | -0.7% |
| 1Y | -35.3% | -11.4% | -14.6% |
Return vs Industry: 600488 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 600488 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 600488 volatility | |
|---|---|
| 600488 Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 600488 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600488's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 2,678 | Shuxiang Li | www.tjpcty.com |
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets.
Tianjin Tianyao Pharmaceuticals Co., Ltd. Fundamentals Summary
| 600488 fundamental statistics | |
|---|---|
| Market cap | CN¥3.96b |
| Earnings (TTM) | CN¥107.59m |
| Revenue (TTM) | CN¥3.66b |
36.0x
P/E Ratio1.1x
P/S RatioIs 600488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600488 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.66b |
| Cost of Revenue | CN¥2.10b |
| Gross Profit | CN¥1.55b |
| Other Expenses | CN¥1.44b |
| Earnings | CN¥107.59m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.098 |
| Gross Margin | 42.44% |
| Net Profit Margin | 2.94% |
| Debt/Equity Ratio | 24.1% |
How did 600488 perform over the long term?
See historical performance and comparison